NISC-6 is a novel dual Topo-IIalpha/Akt inhibitor. NISC-6 has inhibitory activity against various cells, such as UACC903 (IC50 = 2.5 µM) and CHL-1 (IC50 = 0.8 µM) cells. NISC-6 dose dependently induces early and late apoptosis. NISC-6 can be used for research on melanoma[1].
Molecular Weight:
385.32
CAS Number:
[2097636-49-0]
Formula:
C19H18N2O2Se
Target:
Akt,Apoptosis,Topoisomerase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
